Research progress on post-translational modification of proteins and cardiovascular diseases

被引:15
|
作者
Cheng, XueLi [1 ,2 ]
Wang, Kai [2 ]
Zhao, Yan [2 ]
Wang, Kun [1 ,2 ]
机构
[1] Qingdao Univ, Shandong Prov Maternal & Child Hlth Care Hosp, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan 250014, Shandong, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Inst Translat Med, Qingdao 266073, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
INDUCED CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEART-FAILURE; ACTIVATION; INJURY; METHYLATION; SUMOYLATION; EXPRESSION; PROTECTS; PATHWAY;
D O I
10.1038/s41420-023-01560-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiovascular diseases (CVDs) such as atherosclerosis, myocardial remodeling, myocardial ischemia-reperfusion (I/R) injury, heart failure, and oxidative stress are among the greatest threats to human health worldwide. Cardiovascular pathogenesis has been studied for decades, and the influence of epigenetic changes on CVDs has been extensively studied. Post-translational modifications (PTMs), including phosphorylation, glycosylation, methylation, acetylation, ubiquitination, ubiquitin-like and nitrification, play important roles in the normal functioning of the cardiovascular system. Over the past decade, with the application of high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), an increasing number novel acylation modifications have been discovered, including propionylation, crotonylation, butyrylation, succinylation, lactylation, and isonicotinylation. Each change in protein conformation has the potential to alter protein function and lead to CVDs, and this process is usually reversible. This article summarizes the mechanisms underlying several common PTMs involved in the occurrence and development of CVDs.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Research progress on post-translational modification of proteins and cardiovascular diseases
    XueLi Cheng
    Kai Wang
    Yan Zhao
    Kun Wang
    Cell Death Discovery, 9
  • [2] New Types of Post-Translational Modification of Proteins in Cardiovascular Diseases
    Fang, Juntao
    Wu, Shaoyu
    Zhao, Hengli
    Zhou, Chuanmeng
    Xue, Ling
    Lei, Zhiyong
    Li, Hui
    Shan, Zhixin
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2025,
  • [3] Research progress in protein post-translational modification
    HU Jia
    ChineseScienceBulletin, 2006, (06) : 633 - 645
  • [4] Research progress in protein post-translational modification
    Hu Jia
    Guo Yanting
    Li Yanmei
    CHINESE SCIENCE BULLETIN, 2006, 51 (06): : 633 - 645
  • [5] POST-TRANSLATIONAL MODIFICATION OF PROTEINS
    LODISH, HF
    ENZYME AND MICROBIAL TECHNOLOGY, 1981, 3 (03) : 178 - 188
  • [6] Post-translational modification of Parkin and its research progress in cancer
    Ding, Dan
    Ao, Xiang
    Liu, Ying
    Wang, Yuan-Yong
    Fa, Hong-Ge
    Wang, Meng-Yu
    He, Yu-Qi
    Wang, Jian-Xun
    CANCER COMMUNICATIONS, 2019, 39 (01):
  • [7] POST-TRANSLATIONAL COVALENT MODIFICATION OF PROTEINS
    UY, R
    WOLD, F
    SCIENCE, 1977, 198 (4320) : 890 - 896
  • [8] Post-translational modification of PML proteins
    Foertsch, C.
    Distel, L.
    Grabenbauer, G.
    Sauer, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 52 - 52
  • [9] Studying post-translational modification of proteins
    Simons, S
    GENETIC ENGINEERING NEWS, 2004, 24 (04): : 1 - +
  • [10] POST-TRANSLATIONAL MODIFICATION OF PROTEINS BY PHOSPHORYLATION
    TREWAVAS, A
    ANNUAL REVIEW OF PLANT PHYSIOLOGY AND PLANT MOLECULAR BIOLOGY, 1976, 27 : 349 - 374